| CAS NO: | 1315449-72-9 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
Osilodrostat phosphate (formerly LCI-699; LCI699; Isturisa), the phosphate salt of Osilodrostat, is a potent 11β-hydroxylase inhibitor that has been approved in 2020 for the treatment of Cushing's disease.
纯度：≥98%
CAS：1315449-72-9
m.cnreagent.com